China Molecular Diagnostics Market, Test Volume & Forecast
China Molecular Diagnostics Market Overview
China Molecular Diagnostics is a Billion dollar industry and its growing year on year rapidly. Molecular diagnostics holds immense potential in future of China Diagnostics Sector. It is predicted that China will perform over 300 Million molecular diagnostic tests during the forecasting period 2015 – 2019. Infectious disease and Oncology Testing both have almost equal share in China Molecular Diagnostics Sector. However in further sub–segmenting of molecular diagnostics market share perspective Virology Cancer Test holds the highest market share followed by Colorectal cancer and Breast Cancer Test.
Rising demand from middle class for high quality healthcare products, rapid development in the diagnosis of infectious diseases and increasing number of private hospitals are some of the growth drivers which is fueling this sector. However industry faces some kind of challenges such as shortage of lab technicians, lack of expertise in advanced technology in the local companies etc.
This is the 5th report on Molecular Diagnostics industry published by Renub Research. This report titled “China Molecular Diagnostics Market, Test Volume & Forecast” provides a comprehensive assessment of the fast–evolving, high–growth China Molecular diagnostics market. This 84 page report with 55 Figures and 13 Tables studies the China Molecular Diagnostic market from 4 view points:
1) Market & Forecast
2) Application Wise Market & Forecast
3) Application Wise Test Volume & Forecast
4) Profiles of Select Private Clinical Labs & Diagnostic Services Companies
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephonic interviews with industry experts.
Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
China Molecular Diagnostics is a Billion dollar industry and its growing year on year rapidly. Molecular diagnostics holds immense potential in future of China Diagnostics Sector. It is predicted that China will perform over 300 Million molecular diagnostic tests during the forecasting period 2015 – 2019. Infectious disease and Oncology Testing both have almost equal share in China Molecular Diagnostics Sector. However in further sub–segmenting of molecular diagnostics market share perspective Virology Cancer Test holds the highest market share followed by Colorectal cancer and Breast Cancer Test.
Rising demand from middle class for high quality healthcare products, rapid development in the diagnosis of infectious diseases and increasing number of private hospitals are some of the growth drivers which is fueling this sector. However industry faces some kind of challenges such as shortage of lab technicians, lack of expertise in advanced technology in the local companies etc.
This is the 5th report on Molecular Diagnostics industry published by Renub Research. This report titled “China Molecular Diagnostics Market, Test Volume & Forecast” provides a comprehensive assessment of the fast–evolving, high–growth China Molecular diagnostics market. This 84 page report with 55 Figures and 13 Tables studies the China Molecular Diagnostic market from 4 view points:
1) Market & Forecast
2) Application Wise Market & Forecast
3) Application Wise Test Volume & Forecast
4) Profiles of Select Private Clinical Labs & Diagnostic Services Companies
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in–house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephonic interviews with industry experts.
Secondary sources information and data has been collected from various printable and non–printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.
1. EXECUTIVE SUMMARY
2. CHINA MOLECULAR DIAGNOSTIC MARKET & TEST VOLUME FORECAST
2.1 China Molecular Diagnostic Market (2010 – 2019)
2.2 China Molecular Diagnostic Test Volume (2010 – 2019)
3. CHINA MOLECULAR DIAGNOSTIC MARKET & TEST VOLUME SHARE ANALYSIS
3.1 China Molecular Diagnostic Market Share (2010 – 2019)
3.2 China Molecular Diagnostic Application Market Share (2010 – 2019)
3.3 China Molecular Diagnostic Test Volume Share (2010 – 2019)
3.4 China Molecular Diagnostic Test Volume Application Share (2010 – 2019)
4. CHINA MOLECULAR DIAGNOSTIC TEST VOLUME – APPLICATION WISE (2010 – 2019)
4.1 China Molecular Oncology Test Volume Share (2010 – 2019)
4.2 Oncology Test Volume (2010 – 2019)
4.2.1 Breast Cancer Test Volume (2010 – 2019)
4.2.2 Colorectal Cancer Test Volume (2010 – 2019)
4.2.3 Prostate Cancer Test Volume (2010 – 2019)
4.3 China Molecular Infectious Disease Test Volume Share (2010 – 2019)
4.4 Infectious Disease Test Volume (2010 – 2019)
4.4.1 Virology Test Volume (2010 – 2019)
4.4.2 HPV Test Volume (2010 – 2019)
4.5 China Molecular Genetic Test Volume Share (2010 – 2019)
4.6 Genetic Test Volume (2010 – 2019)
4.6.1 Blood Screening Test Volume (2010 – 2019)
4.6.2 HLA Test Volume (2010 – 2019)
5. CHINA MOLECULAR DIAGNOSTIC MARKET & FORECAST – APPLICATION WISE (2010 – 2019)
5.1 China Molecular Oncology Test Market Share (2010 – 2019)
5.2 Oncology Testing Market (2010 – 2019)
5.2.1 Breast Cancer Testing Market (2010 – 2019)
5.2.2 Colorectal Cancer Testing Market (2010 – 2019)
5.2.3 Prostate Cancer Testing Market (2010 – 2019)
5.3 China Molecular Infectious Disease Test Market Share (2010 – 2019)
5.4 Infectious Disease Testing Market (2010 – 2019)
5.4.1 Virology Testing Market (2010 – 2019)
5.4.2 HPV Testing Market (2010 – 2019)
5.5 China Molecular Genetic Test Market Share (2010 – 2019)
5.6 Genetic Testing Market (2010 – 2019)
5.6.1 Blood Screening Market (2010 – 2019)
5.6.2 HLA Testing Market (2010 – 2019)
6. GROWTH DRIVERS
6.1 Increasing Demand from Middle Class for High Quality Healthcare Products
6.2 Rapid Development in the Diagnosis of Infectious Diseases in China
7. CHALLENGES
7.1 Lack of Government Support, Public Awareness & Reimbursement Schemes for Molecular Diagnostics test
7.2 Shortage of Skilled Technicians in China
8. PROFILES OF SELECT PRIVATE CLINICAL LABS AND DIAGNOSTIC SERVICES COMPANIES
8.1 Zhejiang Di’an Diagnostics Technology Co., Ltd.
8.1.1 Company Overview
8.1.2 Products and Services Offered by Di’an
8.2 ADICON Clinical Laboratories (Privately held)
8.2.1 Company Overview
8.2.2 Products and Services Offered by ADICON
8.3 Guangzhou Kingmed Diagnostics Center Co. Ltd.
8.3.1 Company Overview
8.3.2 Products and Services Offered by Kingmed
8.4 Kindstar Global (Privately held)
8.4.1 Company Overview
8.4.2 Products and Services Offered by Kindstar
8.5 BGI–Shenzhen
8.5.1 Company Overview
8.5.2 BGI’s Innovative Approach
8.6 OriGene Technologies
8.6.1 Company Overview
8.6.2 Products and Services Offered by OriGene
2. CHINA MOLECULAR DIAGNOSTIC MARKET & TEST VOLUME FORECAST
2.1 China Molecular Diagnostic Market (2010 – 2019)
2.2 China Molecular Diagnostic Test Volume (2010 – 2019)
3. CHINA MOLECULAR DIAGNOSTIC MARKET & TEST VOLUME SHARE ANALYSIS
3.1 China Molecular Diagnostic Market Share (2010 – 2019)
3.2 China Molecular Diagnostic Application Market Share (2010 – 2019)
3.3 China Molecular Diagnostic Test Volume Share (2010 – 2019)
3.4 China Molecular Diagnostic Test Volume Application Share (2010 – 2019)
4. CHINA MOLECULAR DIAGNOSTIC TEST VOLUME – APPLICATION WISE (2010 – 2019)
4.1 China Molecular Oncology Test Volume Share (2010 – 2019)
4.2 Oncology Test Volume (2010 – 2019)
4.2.1 Breast Cancer Test Volume (2010 – 2019)
4.2.2 Colorectal Cancer Test Volume (2010 – 2019)
4.2.3 Prostate Cancer Test Volume (2010 – 2019)
4.3 China Molecular Infectious Disease Test Volume Share (2010 – 2019)
4.4 Infectious Disease Test Volume (2010 – 2019)
4.4.1 Virology Test Volume (2010 – 2019)
4.4.2 HPV Test Volume (2010 – 2019)
4.5 China Molecular Genetic Test Volume Share (2010 – 2019)
4.6 Genetic Test Volume (2010 – 2019)
4.6.1 Blood Screening Test Volume (2010 – 2019)
4.6.2 HLA Test Volume (2010 – 2019)
5. CHINA MOLECULAR DIAGNOSTIC MARKET & FORECAST – APPLICATION WISE (2010 – 2019)
5.1 China Molecular Oncology Test Market Share (2010 – 2019)
5.2 Oncology Testing Market (2010 – 2019)
5.2.1 Breast Cancer Testing Market (2010 – 2019)
5.2.2 Colorectal Cancer Testing Market (2010 – 2019)
5.2.3 Prostate Cancer Testing Market (2010 – 2019)
5.3 China Molecular Infectious Disease Test Market Share (2010 – 2019)
5.4 Infectious Disease Testing Market (2010 – 2019)
5.4.1 Virology Testing Market (2010 – 2019)
5.4.2 HPV Testing Market (2010 – 2019)
5.5 China Molecular Genetic Test Market Share (2010 – 2019)
5.6 Genetic Testing Market (2010 – 2019)
5.6.1 Blood Screening Market (2010 – 2019)
5.6.2 HLA Testing Market (2010 – 2019)
6. GROWTH DRIVERS
6.1 Increasing Demand from Middle Class for High Quality Healthcare Products
6.2 Rapid Development in the Diagnosis of Infectious Diseases in China
7. CHALLENGES
7.1 Lack of Government Support, Public Awareness & Reimbursement Schemes for Molecular Diagnostics test
7.2 Shortage of Skilled Technicians in China
8. PROFILES OF SELECT PRIVATE CLINICAL LABS AND DIAGNOSTIC SERVICES COMPANIES
8.1 Zhejiang Di’an Diagnostics Technology Co., Ltd.
8.1.1 Company Overview
8.1.2 Products and Services Offered by Di’an
8.2 ADICON Clinical Laboratories (Privately held)
8.2.1 Company Overview
8.2.2 Products and Services Offered by ADICON
8.3 Guangzhou Kingmed Diagnostics Center Co. Ltd.
8.3.1 Company Overview
8.3.2 Products and Services Offered by Kingmed
8.4 Kindstar Global (Privately held)
8.4.1 Company Overview
8.4.2 Products and Services Offered by Kindstar
8.5 BGI–Shenzhen
8.5.1 Company Overview
8.5.2 BGI’s Innovative Approach
8.6 OriGene Technologies
8.6.1 Company Overview
8.6.2 Products and Services Offered by OriGene
LIST OF FIGURES
Figure 2–1: China – Molecular Diagnostic Market (Million US$), 2010 – 2014
Figure 2–2: China – Forecast for Molecular Diagnostic Market (Million US$), 2015 – 2019
Figure 2–3: China – Molecular Diagnostic Test Volume (Million), 2010 – 2014
Figure 2–4: China – Forecast for Molecular Diagnostic Test Volume (Million), 2015 – 2019
Figure 3–1: China – Molecular Diagnostic Market Share (Percent), 2010 – 2014
Figure 3–2: China – Forecast for Molecular Diagnostic Market Share (Percent), 2015 – 2019
Figure 3–5: China – Molecular Diagnostic Test Volume Share (Percent), 2010 – 2014
Figure 3–6: China – Forecast for Molecular Diagnostic Test Volume Share (Percent), 2015 – 2019
Figure 4–1: China – Molecular Oncology Test Volume Share (Percent), 2010 – 2014
Figure 4–2: China – Forecast for Molecular Oncology Test Volume Share (Percent), 2015 – 2019
Figure 4–3: Rural China – Cancer Screening Sites by Cancer Type (Number), 2013
Figure 4–4: China – Oncology Test Volume (Million), 2010 – 2014
Figure 4–5: China – Forecast for Oncology Test Volume (Million), 2015 – 2019
Figure 4–6: China – Breast Cancer Molecular Test Volume (Million), 2010 – 2014
Figure 4–7: China – Forecast for Breast Cancer Molecular Test Volume (Million), 2015 – 2019
Figure 4–8: China – Colorectal Cancer Test Volume (Million), 2010 – 2014
Figure 4–9: China – Forecast for Colorectal Cancer Test Volume (Million), 2015 – 2019
Figure 4–10: China – Prostate Cancer Test Volume (Million), 2010 – 2014
Figure 4–11: China – Forecast for Prostate Cancer Test Volume (Million), 2015 – 2019
Figure 4–14: China – Infectious Disease Test Volume (Million), 2010 – 2014
Figure 4–15: China – Forecast for Infectious Disease Test Volume (Million), 2015 – 2019
Figure 4–16: China – Virology Test Volume (Million), 2010 – 2014
Figure 4–17: China – Forecast for Virology Test Volume (Million), 2015 – 2019
Figure 4–18: China – HPV Test Volume (Million), 2010 – 2014
Figure 4–19: China – Forecast for HPV Test Volume (Million), 2015 – 2019
Figure 4–22: China – Genetic Test Volume (Million), 2010 – 2014
Figure 4–23: China – Forecast for Genetic Test Volume (Million), 2015 – 2019
Figure 4–24: China – Blood Screening Test Volume (Million), 2010 – 2014
Figure 4–25: China – Forecast for Blood Screening Test Volume (Million), 2015 – 2019
Figure 4–26: China – HLA Test Volume (Thousand), 2010 – 2014
Figure 4–27: China – Forecast for HLA Test Volume (Thousand), 2015 – 2019
Figure 5–1: China – Molecular Oncology Test Market Share (Percent), 2010 – 2014
Figure 5–2: China – Forecast for Molecular Oncology Test Market Share (Percent), 2015 – 2019
Figure 5–3: China – Oncology Testing Market (Million US$), 2010 – 2014
Figure 5–4: China – Forecast for Oncology Testing Market (Million US$), 2015 – 2019
Figure 5–5: China – Breast Cancer Testing Market (Million US$), 2010 – 2014
Figure 5–6: China – Forecast for Breast Cancer Testing Market (Million US$), 2015 – 2019
Figure 5–7: China – Colorectal Cancer Testing Market (Million US$), 2010 – 2014
Figure 5–8: China – Forecast for Colorectal Cancer Testing Market (Million US$), 2015 – 2019
Figure 5–9: China – Prostate Cancer Testing Market (Million US$), 2010 – 2014
Figure 5–10: China – Forecast for Prostate Cancer Testing Market (Million US$), 2015 – 2019
Figure 5–13: China – Infectious Disease Testing Market (Million US$), 2010 – 2014
Figure 5–14: China – Forecast for Infectious Disease Testing Market (Million US$), 2015 – 2019
Figure 5–15: China – Virology Testing Market (Million US$), 2010 – 2014
Figure 5–16: China – Forecast for Virology Testing Market (Million US$), 2015 – 2019
Figure 5–17: China – HPV Testing Market (Million US$), 2010 – 2014
Figure 5–18: China – Forecast for HPV Testing Market (Million US$), 2015 – 2019
Figure 5–21: China – Genetic Testing Market (Million US$), 2010 – 2014
Figure 5–22: China – Forecast for Genetic Testing Market (Million US$), 2015 – 2019
Figure 5–23: China – Blood Screening Market (Million US$), 2010 – 2014
Figure 5–24: China – Forecast for Blood Screening Market (Million US$), 2015 – 2019
Figure 5–25: China – HLA Testing Market (Million US$), 2010 – 2014
Figure 5–26: China – Forecast for HLA Testing Market (Million US$), 2015 – 2019
Figure 6–1: China – Healthcare Spending (Billion US$), 2011 & 2020
Figure 8–1: Kindstar – Collaboration with Hospitals in China (Number), 2006 – 2012
Figure 2–1: China – Molecular Diagnostic Market (Million US$), 2010 – 2014
Figure 2–2: China – Forecast for Molecular Diagnostic Market (Million US$), 2015 – 2019
Figure 2–3: China – Molecular Diagnostic Test Volume (Million), 2010 – 2014
Figure 2–4: China – Forecast for Molecular Diagnostic Test Volume (Million), 2015 – 2019
Figure 3–1: China – Molecular Diagnostic Market Share (Percent), 2010 – 2014
Figure 3–2: China – Forecast for Molecular Diagnostic Market Share (Percent), 2015 – 2019
Figure 3–5: China – Molecular Diagnostic Test Volume Share (Percent), 2010 – 2014
Figure 3–6: China – Forecast for Molecular Diagnostic Test Volume Share (Percent), 2015 – 2019
Figure 4–1: China – Molecular Oncology Test Volume Share (Percent), 2010 – 2014
Figure 4–2: China – Forecast for Molecular Oncology Test Volume Share (Percent), 2015 – 2019
Figure 4–3: Rural China – Cancer Screening Sites by Cancer Type (Number), 2013
Figure 4–4: China – Oncology Test Volume (Million), 2010 – 2014
Figure 4–5: China – Forecast for Oncology Test Volume (Million), 2015 – 2019
Figure 4–6: China – Breast Cancer Molecular Test Volume (Million), 2010 – 2014
Figure 4–7: China – Forecast for Breast Cancer Molecular Test Volume (Million), 2015 – 2019
Figure 4–8: China – Colorectal Cancer Test Volume (Million), 2010 – 2014
Figure 4–9: China – Forecast for Colorectal Cancer Test Volume (Million), 2015 – 2019
Figure 4–10: China – Prostate Cancer Test Volume (Million), 2010 – 2014
Figure 4–11: China – Forecast for Prostate Cancer Test Volume (Million), 2015 – 2019
Figure 4–14: China – Infectious Disease Test Volume (Million), 2010 – 2014
Figure 4–15: China – Forecast for Infectious Disease Test Volume (Million), 2015 – 2019
Figure 4–16: China – Virology Test Volume (Million), 2010 – 2014
Figure 4–17: China – Forecast for Virology Test Volume (Million), 2015 – 2019
Figure 4–18: China – HPV Test Volume (Million), 2010 – 2014
Figure 4–19: China – Forecast for HPV Test Volume (Million), 2015 – 2019
Figure 4–22: China – Genetic Test Volume (Million), 2010 – 2014
Figure 4–23: China – Forecast for Genetic Test Volume (Million), 2015 – 2019
Figure 4–24: China – Blood Screening Test Volume (Million), 2010 – 2014
Figure 4–25: China – Forecast for Blood Screening Test Volume (Million), 2015 – 2019
Figure 4–26: China – HLA Test Volume (Thousand), 2010 – 2014
Figure 4–27: China – Forecast for HLA Test Volume (Thousand), 2015 – 2019
Figure 5–1: China – Molecular Oncology Test Market Share (Percent), 2010 – 2014
Figure 5–2: China – Forecast for Molecular Oncology Test Market Share (Percent), 2015 – 2019
Figure 5–3: China – Oncology Testing Market (Million US$), 2010 – 2014
Figure 5–4: China – Forecast for Oncology Testing Market (Million US$), 2015 – 2019
Figure 5–5: China – Breast Cancer Testing Market (Million US$), 2010 – 2014
Figure 5–6: China – Forecast for Breast Cancer Testing Market (Million US$), 2015 – 2019
Figure 5–7: China – Colorectal Cancer Testing Market (Million US$), 2010 – 2014
Figure 5–8: China – Forecast for Colorectal Cancer Testing Market (Million US$), 2015 – 2019
Figure 5–9: China – Prostate Cancer Testing Market (Million US$), 2010 – 2014
Figure 5–10: China – Forecast for Prostate Cancer Testing Market (Million US$), 2015 – 2019
Figure 5–13: China – Infectious Disease Testing Market (Million US$), 2010 – 2014
Figure 5–14: China – Forecast for Infectious Disease Testing Market (Million US$), 2015 – 2019
Figure 5–15: China – Virology Testing Market (Million US$), 2010 – 2014
Figure 5–16: China – Forecast for Virology Testing Market (Million US$), 2015 – 2019
Figure 5–17: China – HPV Testing Market (Million US$), 2010 – 2014
Figure 5–18: China – Forecast for HPV Testing Market (Million US$), 2015 – 2019
Figure 5–21: China – Genetic Testing Market (Million US$), 2010 – 2014
Figure 5–22: China – Forecast for Genetic Testing Market (Million US$), 2015 – 2019
Figure 5–23: China – Blood Screening Market (Million US$), 2010 – 2014
Figure 5–24: China – Forecast for Blood Screening Market (Million US$), 2015 – 2019
Figure 5–25: China – HLA Testing Market (Million US$), 2010 – 2014
Figure 5–26: China – Forecast for HLA Testing Market (Million US$), 2015 – 2019
Figure 6–1: China – Healthcare Spending (Billion US$), 2011 & 2020
Figure 8–1: Kindstar – Collaboration with Hospitals in China (Number), 2006 – 2012
LIST OF TABLES
Table 3–1: China – Molecular Diagnostic Application Market Share (Percent), 2010 – 2014
Table 3–2: China – Forecast for Molecular Diagnostic Application Market Share (Percent), 2015 – 2019
Table 3–3: China – Molecular Diagnostic Test Volume Application Share (Percent), 2010 – 2014
Table 3–4: China – Forecast for Molecular Diagnostic Test Volume Application Share (Percent), 2015 – 2019
Table 4–1: China – Molecular Infectious Disease Test Volume Share (Percent), 2010 – 2014
Table 4–2: China – Forecast for Molecular Infectious Disease Test Volume Share (Percent), 2015 – 2019.
Table 4–3: China – Molecular Genetic Test Volume Share (Percent), 2010 – 2014
Table 4–4: China – Forecast for Molecular Genetic Test Volume Share (Percent), 2015 – 2019
Table 5–1: China – Molecular Infectious Disease Test Market Share (Percent), 2010 – 2014
Table 5–2: China – Forecast for Molecular Infectious Disease Test Market Share (Percent), 2015 – 2019
Table 5–3: China – Molecular Genetic Test Market Share (Percent), 2010 – 2014
Table 5–4: China – Forecast for Molecular Genetic Test Market Share (Percent), 2015 – 2019
Table 6–1: China – Major Diagnostic Reagent R&D and Manufacturing Companies in Infectious Diseases, 2010
Table 3–1: China – Molecular Diagnostic Application Market Share (Percent), 2010 – 2014
Table 3–2: China – Forecast for Molecular Diagnostic Application Market Share (Percent), 2015 – 2019
Table 3–3: China – Molecular Diagnostic Test Volume Application Share (Percent), 2010 – 2014
Table 3–4: China – Forecast for Molecular Diagnostic Test Volume Application Share (Percent), 2015 – 2019
Table 4–1: China – Molecular Infectious Disease Test Volume Share (Percent), 2010 – 2014
Table 4–2: China – Forecast for Molecular Infectious Disease Test Volume Share (Percent), 2015 – 2019.
Table 4–3: China – Molecular Genetic Test Volume Share (Percent), 2010 – 2014
Table 4–4: China – Forecast for Molecular Genetic Test Volume Share (Percent), 2015 – 2019
Table 5–1: China – Molecular Infectious Disease Test Market Share (Percent), 2010 – 2014
Table 5–2: China – Forecast for Molecular Infectious Disease Test Market Share (Percent), 2015 – 2019
Table 5–3: China – Molecular Genetic Test Market Share (Percent), 2010 – 2014
Table 5–4: China – Forecast for Molecular Genetic Test Market Share (Percent), 2015 – 2019
Table 6–1: China – Major Diagnostic Reagent R&D and Manufacturing Companies in Infectious Diseases, 2010
